Gland Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2017
Period Ending	Nov '24 Nov 14, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	2019 - 2017
Market Capitalization	292,270	303,932	208,882	537,705	405,432	-	Upgrade
Market Cap Growth	7.24%	45.50%	-61.15%	32.63%	-	-	Upgrade
Enterprise Value	267,335	286,055	175,977	508,469	390,204	-	Upgrade
Last Close Price	1774.00	1826.40	1255.30	3239.23	2452.99	-	Upgrade
PE Ratio	42.26	38.95	26.47	43.99	38.94	-	Upgrade
PS Ratio	4.96	5.37	5.76	12.22	11.71	-	Upgrade
PB Ratio	3.32	3.48	2.62	7.51	6.87	-	Upgrade
P/FCF Ratio	35.12	50.08	146.03	192.42	107.78	-	Upgrade
P/OCF Ratio	24.28	30.49	57.39	68.00	67.02	-	Upgrade
EV/Sales Ratio	4.54	5.05	4.86	11.55	11.27	-	Upgrade
EV/EBITDA Ratio	20.94	21.77	17.07	33.67	29.97	-	Upgrade
EV/EBIT Ratio	29.94	28.94	19.90	36.32	32.42	-	Upgrade
EV/FCF Ratio	32.12	47.14	123.03	181.96	103.74	-	Upgrade
Debt / Equity Ratio	0.04	0.04	0.00	0.00	0.00	0.00	Upgrade
Debt / EBITDA Ratio	0.26	0.28	0.00	0.00	0.00	0.01	Upgrade
Debt / FCF Ratio	0.39	0.61	0.03	0.02	0.01	0.01	Upgrade
Asset Turnover	0.56	0.58	0.44	0.61	0.65	0.69	Upgrade
Inventory Turnover	1.48	1.40	1.16	1.79	1.56	1.43	Upgrade
Quick Ratio	2.80	2.61	6.58	7.80	7.31	5.50	Upgrade
Current Ratio	4.16	4.04	9.46	10.05	10.00	7.93	Upgrade
Return on Equity (ROE)	8.09%	9.26%	10.33%	18.55%	20.88%	23.75%	Upgrade
Return on Assets (ROA)	5.27%	6.36%	6.66%	12.21%	14.22%	14.14%	Upgrade
Return on Capital (ROIC)	6.28%	7.24%	7.31%	13.39%	15.73%	16.50%	Upgrade
Earnings Yield	2.37%	2.54%	3.74%	2.25%	2.46%	-	Upgrade
FCF Yield	2.85%	2.00%	0.68%	0.52%	0.93%	-	Upgrade
Dividend Yield	1.17%	1.10%	-	-	-	-	Upgrade
Buyback Yield / Dilution	-0.00%	-0.03%	-0.09%	-3.95%	-2.15%	-	Upgrade
Total Shareholder Return	1.17%	1.06%	-0.09%	-3.95%	-2.15%	-	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.